Abstract
If replication trials support these findings, safeguards will need to be established to guard against the risk of abuse while ensuring access to those patients who may benefit from esketamine.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
